Clariane SE (PA:CLARI) — Market Cap & Net Worth
Market Cap & Net Worth: Clariane SE (CLARI)
Clariane SE (PA:CLARI) has a market capitalization of $1.43 Billion (€1.22 Billion) as of September 16, 2026. Listed on the PA stock exchange, this France-based company holds position #7422 globally and #123 in its home market, demonstrating a -0.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Clariane SE's stock price €3.93 by its total outstanding shares 357286663 (357.29 Million). Also see Clariane SE total assets for a full breakdown of the balance sheet.
Clariane SE Market Cap History: 2015 to 2026
Clariane SE's market capitalization history from 2015 to 2026. Data shows change from $6.99 Billion to $1.64 Billion (-12.47% CAGR). Also see Clariane SE cash conversion from operations for how efficiently the company converts equity into cash flow.
Index Memberships
Clariane SE is a constituent of 6 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC Mid 60
CACMD
|
$193.66 Billion | 0.74% | #36 of 55 |
|
CAC Mid & Small
CACMS
|
$230.53 Billion | 0.62% | #44 of 119 |
|
CAC All-Tradable
CACT
|
$2.85 Trillion | 0.05% | #102 of 179 |
|
CAC All-Tradable Net Total Return
CACTN
|
$2.85 Trillion | 0.05% | #102 of 179 |
|
CAC All Tradable Gross Total Return
CACTR
|
$2.85 Trillion | 0.05% | #102 of 179 |
|
CAC Health Care
FRHC
|
$241.84 Billion | 0.59% | #9 of 36 |
Weight: Clariane SE's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Clariane SE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Clariane SE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Clariane SE stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.31x
Clariane SE's market cap is 0.31 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1027.03x
Clariane SE's market cap is 1027.03 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.91 Billion | $2.98 Billion | $131.29 Million | 1.98x | 45.03x |
| 2017 | $6.37 Billion | $3.13 Billion | $163.32 Million | 2.04x | 39.03x |
| 2018 | $6.87 Billion | $3.34 Billion | $123.13 Million | 2.06x | 55.80x |
| 2019 | $9.42 Billion | $3.61 Billion | $114.68 Million | 2.61x | 82.15x |
| 2020 | $7.63 Billion | $3.77 Billion | $39.40 Million | 2.02x | 193.53x |
| 2021 | $6.84 Billion | $4.14 Billion | $91.11 Million | 1.65x | 75.07x |
| 2022 | $2.55 Billion | $4.44 Billion | $22.06 Million | 0.57x | 115.41x |
| 2023 | $626.22 Million | $5.00 Billion | -$105.25 Million | 0.13x | N/A |
| 2024 | $872.17 Million | $5.28 Billion | -$55.12 Million | 0.17x | N/A |
| 2025 | $1.64 Billion | $5.31 Billion | $1.60 Million | 0.31x | 1027.03x |
Competitor Companies of CLARI by Market Capitalization
Companies near Clariane SE in the global market cap rankings as of September 16, 2026. Review how tangible is Clariane SE's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Clariane SE by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #288 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #911 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1001 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1234 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #288 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $423.82 |
| #911 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.39 |
| #1001 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1234 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $260.85 |
Clariane SE Historical Marketcap From 2015 to 2026
Between 2015 and today, Clariane SE's market cap moved from $6.99 Billion to $ 1.64 Billion, with a yearly change of -12.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.64 Billion | 0.00% |
| 2025 | €1.64 Billion | +88.41% |
| 2024 | €872.17 Million | +39.27% |
| 2023 | €626.22 Million | -75.40% |
| 2022 | €2.55 Billion | -62.78% |
| 2021 | €6.84 Billion | -10.30% |
| 2020 | €7.63 Billion | -19.06% |
| 2019 | €9.42 Billion | +37.11% |
| 2018 | €6.87 Billion | +7.79% |
| 2017 | €6.37 Billion | +7.81% |
| 2016 | €5.91 Billion | -15.46% |
| 2015 | €6.99 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Clariane SE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.43 Billion USD |
| MoneyControl | $1.43 Billion USD |
| MarketWatch | $1.43 Billion USD |
| marketcap.company | $1.43 Billion USD |
| Reuters | $1.43 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Clariane SE
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care … Read more